BioMap and Tsinghua University School of Biomedical Engineering Forge Strategic Partnership to Advance 'AI for Life Science' Innovation and Translation

2025Year1Month9Day，BioMap Announces Partnership withSchool of Biomedical Engineering, Tsinghua UniversityReach Strategic Cooperation,Co-writing“AI for Life Science”A New Chapter of Cutting-Edge Integration.Both parties will leverage their respective resource and technological advantages in biomedical research-relatedArtificial Intelligence (AI) to deeply cooperate in the fields of model development and application, jointly promoting the innovation and transformation of life science technologies. This collaboration aims to utilizeBioMap's Life Science Foundation Large Model Platform and Supporting Intelligent Agents Accelerate the Implementation of Research Results, Promoting High-Quality Development in the Field of Life Sciences. The collaboration will promote innovation in the field of life sciences at Tsinghua University's School of Biomedical Engineering from multiple perspectives including scientific research, scientific validation, achievement transformation, research services, and talent cultivation. Both parties will jointly push artificial intelligence technology to become a new paradigm for solving major scientific problems in fundamental disciplines.

Huang Tianyin, Vice Provost of Tsinghua University and Dean of the School of Medicine, and Deng Yongfu, President of BioMap, delivered speeches on behalf of their respective parties. Liu Peng, Secretary of the Party Committee of the School of Biomedical Engineering at Tsinghua University, Wang Guangzhi, Executive Dean, Du Yanan, Vice Dean, and Zhao Binghui, General Manager of the Science and Education Industry at BioMap, among other key leaders from both sides, attended the signing ceremony and participated in discussions.

Through this strategic cooperation, BioMap and the School of Biomedical Engineering at Tsinghua University will engage in in-depth collaboration in the fields of medical imaging, multi-omics, neural engineering, and micro-nano medicine. By combining the extensive research capabilities accumulated over the years by the School of Biomedical Engineering at Tsinghua University with BioMap's leading large model technology, both parties will focus on comprehensive cooperation in scientific validation research, collaborative research projects, transformation of research achievements, research service support, and talent cultivation. Both parties hope to significantly enhance artificial intelligence technology.+The social awareness of combining scientific research with medical scenarios, cultivating more cross-disciplinary talents with practical abilities, and jointly promoting the vigorous development of China's AI-driven life health industry.

Vice Dean of Academic Affairs, MedicinePresident Huang TianyinIntroduced the historical evolution, scientific and technological innovation of Tsinghua Medicine, as well as the development and mission of the School of Biomedical Engineering. He stated.Tsinghua Medicine Based on Tsinghua UniversityThe comprehensive advantages of engineering disciplines fully promote the integration of medicine and engineering. The School of Biomedical Engineering is at the forefront of the development of this integration and is also a key discipline for Tsinghua Medicine as it enters a new phase.For more than four decades, the discipline of biomedical engineering has consistently upheld its historical mission of exploring the frontiers of health care technology, cultivating leaders in medical equipment, and serving the "Healthy China" initiative.2025 is the final year of the "14th Five-Year Plan" and also the planning year for the "15th Five-Year Plan." The collaboration between BioMap and the School of Biomedical Engineering to build a highland for artificial intelligence in biomedicine holds significant importance for the high-quality development of Tsinghua Medicine and the integration of medicine and engineering.It is hoped that the two parties will take the signing of this agreement as an opportunity to gradually broaden cooperation channels, enrich cooperation forms, and strive to promote the high-quality development of school-enterprise cooperation and intelligent healthcare.

BioMap President Deng Yongfu thanked the School of Biomedical Engineering at Tsinghua University for its trust in BioMap. He stated that BioMap, as a global leader in the life sciences industry,Learn Large Model Platform PublicBioMap has successfully developed more than 200 task models covering key areas such as drug research and development and biomanufacturing, reaching SOTA levels. Through this collaboration, BioMap will comprehensively promote and advance the research and implementation of results at the College of Biomedical Engineering, based on its large AI model for life sciences and accompanying intelligent systems, establishing an industry-leading application beacon for the use of large AI models in the biomedical industry and scientific research fields. Additionally, BioMap will continue to strengthen university-enterprise cooperation, creating an industry benchmark for the application of artificial intelligence + biomedicine, while jointly driving and leading the vigorous development of China’s AI + biomedicine industry.

This cooperation between the two parties,BioMap andSchool of Biomedical Engineering, Tsinghua UniversityWill jointly exploreAIFrontier Technology ResearchAnd Application LandingTheNew Scenario，Strengthen the Deep Integration of Medicine, Education, Research, and Industry，Further Promote UniversitiesResearch AchievementsApplication and Innovation，A New Momentum for the Development of China's AI and Life Sciences Fields。

About BioMap

BioMap is a pioneer in the global life sciences foundational large model field. With a cross-modal biological language large model of 210 billion parameters, it decodes underlying principles such as genomes, proteins, cells, and biological systems, while consuming less data and cost to build high-quality AI task models for life sciences. Currently, BioMap has achieved State-of-the-Art (SOTA) performance in over 200 task models across drug discovery, biomanufacturing, healthcare, and other fields, serving more than 400 users globally. Its signed orders have a potential value of nearly $2 billion, enabling users to achieve numerous breakthroughs in areas like AI-driven protein design, AI-based target discovery, and AI enzyme design. The company was co-founded by Robin Li, the founder of Baidu, and Liu Wei, former CEO of Baidu Ventures. Its core team includes industry executives such as the former Global Vice President of Novo Nordisk and the former Global Vice President of SAP. Research and development centers have been established in Silicon Valley, Beijing, Suzhou, and Hong Kong. The company has received over $200 million in venture capital funding.

About the School of Biomedical Engineering, Tsinghua University

The School of Biomedical Engineering at Tsinghua University is one of the first established disciplines in biomedical engineering in China and is a national key discipline in biomedical engineering. The school began enrolling master’s students in 1979, undergraduate students in 1982, and doctoral students in 1986. In 2011, it was selected for the Ministry of Education's "Outstanding Engineer Education and Training Plan," in 2017 it was included in the Ministry of Education's "Double First-Class" initiative, and in 2019 it was chosen as one of the first undergraduate programs under the "Double Ten Thousand Plan" for top-tier majors. Exploring cutting-edge healthcare technology, cultivating leaders in medical equipment, and serving the "Healthy China" initiative are the core missions of the School of Biomedical Engineering.